Clinical Pharmacokinetics of IPX066: Evaluation of Dose Proportionality and Effect of Food in Healthy Volunteers

Por Yao, Hsuan-Ming, Hsu, Ann, Gupta, Suneel, Modi, Nishit B.
Publicado no Clin Neuropharmacol (2016)

The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease: A Post Hoc Analysis

Por LeWitt, Peter A., Poewe, Werner, Elmer, Lawrence W., Asgharnejad, Mahnaz, Boroojerdi, Babak, Grieger, Frank, Bauer, Lars
Publicado no Clin Neuropharmacol (2016)

Comparison of Selegiline and Rasagiline Therapies in Parkinson Disease: A Real-life Study

Por Peretz, Chava, Segev, Hagar, Rozani, Violet, Gurevich, Tanya, El-Ad, Baruch, Tsamir, Judith, Giladi, Nir
Publicado no Clin Neuropharmacol (2016)

Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients

Por Kitta, Takeya, Yabe, Ichiro, Kanno, Yukiko, Higuchi, Madoka, Ouchi, Mifuka, Togo, Mio, Moriya, Kimihiko, Takahashi, Ikuko, Matsushima, Masaaki, Sasaki, Hidenao, Shinohara, Nobuo
Publicado no Clin Neuropharmacol (2018)

Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis

Por LeWitt, Peter A., Verhagen Metman, Leo, Rubens, Robert, Khanna, Sarita, Kell, Sherron, Gupta, Suneel
Publicado no Clin Neuropharmacol (2018)